ANJALI JAIN, M.D.
Osteopathic Medicine at State St, Los Angeles, CA
License number
California A113442
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
1200 NORTH State St, Los Angeles, CA 90031
3755 Savona Ct, Chino, CA 91710
3755 Savona Ct, Chino, CA 91710
Phone
(909) 910-5246
Professional information
Dr. Anjali Jain, Los Angeles CA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism
Address:
1200 N State St, Los Angeles 90033
(909) 910-5246 (Phone)
6776 Southwest Fwy STE 400, Houston 77074
(713) 272-8884 (Phone), (713) 272-0898 (Fax)
LOS ANGELES CITY UNIVERSITY SOUTHERN CALIFORNIA
1200 N State St, Los Angeles 90033
(909) 910-5246 (Phone)
22330 Hawthorne Blvd STE 207, Torrance 90505
(310) 375-7666 (Phone), (310) 373-5556 (Fax)
(909) 910-5246 (Phone)
6776 Southwest Fwy STE 400, Houston 77074
(713) 272-8884 (Phone), (713) 272-0898 (Fax)
LOS ANGELES CITY UNIVERSITY SOUTHERN CALIFORNIA
1200 N State St, Los Angeles 90033
(909) 910-5246 (Phone)
22330 Hawthorne Blvd STE 207, Torrance 90505
(310) 375-7666 (Phone), (310) 373-5556 (Fax)
Languages:
English
Education:
Medical School
Ross University / School of Medicine & Veterinary Medicine
Ross University / School of Medicine & Veterinary Medicine
Anjali Jain
Location:
Greater Los Angeles Area
Industry:
Research
Skills:
Cancer, Molecular Biology, Oncology, Immunology, Cell Biology
Composition And Method For The Treatment Of Cancer And Other Physiologic Conditins Based On Modulation Of The Ppar-Gamma Pathway And Her-Kinase Axis
US Patent:
2007010, May 10, 2007
Filed:
Aug 27, 2004
Appl. No.:
10/568669
Inventors:
David Agus - Beverly Hills CA, US
Anjali Jain - Los Angeles CA, US
Michael Hedvat - Encino CA, US
Anjali Jain - Los Angeles CA, US
Michael Hedvat - Encino CA, US
Assignee:
CEDARS-SINAI MEDICAL CENTER - Los Angeles CA
International Classification:
A61K 39/395, A61K 31/60, A61K 31/405, A61K 31/192
US Classification:
424146100, 514165000, 514420000, 514569000, 514570000
Abstract:
Described herein are methods of using a NSAID and a HER-kinase axis inhibitor in the treatment of various conditions including cancer, and especially prostate, breast, lung, ovarian, brain and colon cancers, through regulation of PPARĪ³ activity. In various embodiments, the NSAID and HER-kinase axis inhibitor may be included in a composition that is useful for the treatment of conditions in a mammal. Also described is a kit including a NSAID and a HER-kinase axis inhibitor along with instructions for their use in treating and preventing disease conditions, such as cancer.